Oncternal Therapeutics, Inc. engages in the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Its product pipeline include Zilovertamab, ONCT-216, ONCT-808 and ONCT-534. The company was founded by David F. Hale and James B. Breitmeyer in September 1997 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Oncternal Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Oncternal Therapeutics Inc market cap is $1.56M.
What is the 52-week high for Oncternal Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Oncternal Therapeutics Inc 52 week high is $2.37 as of September 28, 2025.
What is the 52-week low for Oncternal Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Oncternal Therapeutics Inc 52 week low is $0.5266 as of September 28, 2025.
What is Oncternal Therapeutics Inc stock price today?
Oncternal Therapeutics Inc stock price today is $0.5266.
What was Oncternal Therapeutics Inc stock price yesterday?
Oncternal Therapeutics Inc stock price yesterday was $0.6939.
What is the PE ratio of Oncternal Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Oncternal Therapeutics Inc’s P/E ratio is -0.05.
What is the Price-to-Book ratio of Oncternal Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Oncternal Therapeutics Inc P/B ratio is 0.1704.
What is the 50-day moving average of Oncternal Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Oncternal Therapeutics Inc 50-day moving average is $0.5266.
